Literature DB >> 3728641

Frequency distribution of early glaucomatous visual field defects.

D B Henson, A J Hobley.   

Abstract

The optimization of visual field screening programs for glaucoma requires precise knowledge of where glaucoma defects occur and whether any relation exists between the size of defects and the associated retinal disease. The visual field results from 109 eyes of patients with early glaucomatous damage were investigated with a Friedmann Mark II Visual Field Analyser. The frequency distribution of scotomas as a function of location demonstrated that the tested field could be divided into four zones, one where scotomas occur frequently, one where scotomas occur a reasonable number of times, one where scotomas occur rarely, and one which corresponds to the blind spot (BS) region. The distribution of scotoma size in the first three zones was found to be about the same. Differences among the distributions of defects measured in this study and those of previous studies are attributed to different examination techniques.

Entities:  

Mesh:

Year:  1986        PMID: 3728641     DOI: 10.1097/00006324-198606000-00010

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  4 in total

1.  Cluster analysis in visual field quantification.

Authors:  B C Chauhan; D B Henson; A J Hobley
Journal:  Doc Ophthalmol       Date:  1988-05       Impact factor: 2.379

2.  Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

Review 3.  Clinical Utility of Optical Coherence Tomography in Glaucoma.

Authors:  Zachary M Dong; Gadi Wollstein; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

4.  Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage.

Authors:  Ryan Caezar C David; Sasan Moghimi; Jiun L Do; Huiyuan Hou; James Proudfoot; Linda M Zangwill; Alireza Kamalipour; Takashi Nishida; Carlos Gustavo De Moraes; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2021-06-06       Impact factor: 5.488

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.